Incidental Mutation 'R2343:Smoc2'
ID |
245909 |
Institutional Source |
Beutler Lab
|
Gene Symbol |
Smoc2
|
Ensembl Gene |
ENSMUSG00000023886 |
Gene Name |
SPARC related modular calcium binding 2 |
Synonyms |
5430426J21Rik, 1700056C05Rik, Smoc2l |
Accession Numbers |
|
Essential gene? |
Non essential
(E-score: 0.000)
|
Stock # |
R2343 (G1)
|
Quality Score |
225 |
Status
|
Not validated
|
Chromosome |
17 |
Chromosomal Location |
14499768-14625052 bp(+) (GRCm39) |
Type of Mutation |
missense |
DNA Base Change (assembly) |
A to G
at 14564604 bp (GRCm39)
|
Zygosity |
Heterozygous |
Amino Acid Change |
Lysine to Arginine
at position 160
(K160R)
|
Ref Sequence |
ENSEMBL: ENSMUSP00000024660
(fasta)
|
Gene Model |
predicted gene model for transcript(s):
[ENSMUST00000024660]
|
AlphaFold |
Q8CD91 |
Predicted Effect |
probably benign
Transcript: ENSMUST00000024660
AA Change: K160R
PolyPhen 2
Score 0.220 (Sensitivity: 0.91; Specificity: 0.88)
|
SMART Domains |
Protein: ENSMUSP00000024660 Gene: ENSMUSG00000023886 AA Change: K160R
Domain | Start | End | E-Value | Type |
signal peptide
|
1 |
21 |
N/A |
INTRINSIC |
KAZAL
|
39 |
84 |
1.49e-12 |
SMART |
TY
|
110 |
157 |
3.07e-14 |
SMART |
low complexity region
|
166 |
177 |
N/A |
INTRINSIC |
TY
|
237 |
285 |
3.34e-15 |
SMART |
Pfam:SPARC_Ca_bdg
|
302 |
412 |
8.6e-13 |
PFAM |
|
Coding Region Coverage |
- 1x: 99.3%
- 3x: 98.7%
- 10x: 97.4%
- 20x: 95.3%
|
Validation Efficiency |
|
MGI Phenotype |
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a member of the SPARC family (secreted protein acidic and rich in cysteine/osteonectin/BM-40), which are highly expressed during embryogenesis and wound healing. The gene product is a matricellular protein which promotes matrix assembly and can stimulate endothelial cell proliferation and migration, as well as angiogenic activity. Associated with pulmonary function, this secretory gene product contains a Kazal domain, two thymoglobulin type-1 domains, and two EF-hand calcium-binding domains. The encoded protein may serve as a target for controlling angiogenesis in tumor growth and myocardial ischemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009] PHENOTYPE: Mice homozygous for one KO allele exhibit protection from induced kidney fibrosis and reduced interstitial myofibroblast accumulation. Another KO allele leads to shortening and widening of the skull. [provided by MGI curators]
|
Allele List at MGI |
|
Other mutations in this stock |
Total: 21 list
Gene | Ref | Var | Chr/Loc | Mutation | Predicted Effect | Zygosity |
Bcr |
T |
C |
10: 74,981,254 (GRCm39) |
I691T |
probably benign |
Het |
Col20a1 |
A |
G |
2: 180,643,124 (GRCm39) |
T865A |
possibly damaging |
Het |
Dmxl1 |
G |
A |
18: 50,023,745 (GRCm39) |
R1676H |
probably damaging |
Het |
Dsg2 |
T |
C |
18: 20,735,355 (GRCm39) |
V1111A |
probably damaging |
Het |
Eif3g |
T |
C |
9: 20,806,450 (GRCm39) |
Y213C |
probably damaging |
Het |
Fat4 |
C |
T |
3: 39,011,254 (GRCm39) |
S2118F |
probably damaging |
Het |
Gpr85 |
A |
G |
6: 13,836,695 (GRCm39) |
S70P |
probably damaging |
Het |
Krtap31-1 |
A |
C |
11: 99,798,847 (GRCm39) |
T17P |
possibly damaging |
Het |
Lig1 |
A |
G |
7: 13,026,121 (GRCm39) |
|
probably null |
Het |
Lman2l |
A |
T |
1: 36,467,190 (GRCm39) |
D269E |
possibly damaging |
Het |
Mcc |
A |
G |
18: 44,592,864 (GRCm39) |
|
probably null |
Het |
Nav2 |
T |
C |
7: 49,248,565 (GRCm39) |
F2302L |
possibly damaging |
Het |
Nsf |
C |
T |
11: 103,821,578 (GRCm39) |
E26K |
possibly damaging |
Het |
Or13p4 |
C |
A |
4: 118,547,384 (GRCm39) |
M88I |
probably benign |
Het |
Or4k38 |
A |
G |
2: 111,166,045 (GRCm39) |
I126T |
probably damaging |
Het |
Sema6c |
T |
C |
3: 95,074,394 (GRCm39) |
F67L |
probably damaging |
Het |
Sez6l |
A |
T |
5: 112,612,597 (GRCm39) |
V448D |
probably damaging |
Het |
Spata2 |
A |
T |
2: 167,325,280 (GRCm39) |
V513E |
probably damaging |
Het |
Susd3 |
T |
A |
13: 49,392,335 (GRCm39) |
M107L |
probably damaging |
Het |
Tnni3k |
A |
G |
3: 154,644,466 (GRCm39) |
I564T |
probably benign |
Het |
Zfp971 |
A |
G |
2: 177,674,787 (GRCm39) |
K129E |
possibly damaging |
Het |
|
Other mutations in Smoc2 |
Allele | Source | Chr | Coord | Type | Predicted Effect | PPH Score |
IGL01625:Smoc2
|
APN |
17 |
14,545,876 (GRCm39) |
missense |
probably damaging |
1.00 |
IGL02085:Smoc2
|
APN |
17 |
14,567,495 (GRCm39) |
missense |
possibly damaging |
0.79 |
IGL02309:Smoc2
|
APN |
17 |
14,595,789 (GRCm39) |
splice site |
probably benign |
|
IGL02975:Smoc2
|
APN |
17 |
14,556,872 (GRCm39) |
missense |
probably damaging |
0.98 |
enamel
|
UTSW |
17 |
14,545,896 (GRCm39) |
missense |
probably damaging |
1.00 |
FR4976:Smoc2
|
UTSW |
17 |
14,621,824 (GRCm39) |
small deletion |
probably benign |
|
R2291:Smoc2
|
UTSW |
17 |
14,589,233 (GRCm39) |
missense |
possibly damaging |
0.53 |
R2888:Smoc2
|
UTSW |
17 |
14,617,887 (GRCm39) |
critical splice donor site |
probably null |
|
R3878:Smoc2
|
UTSW |
17 |
14,545,879 (GRCm39) |
missense |
probably damaging |
1.00 |
R4872:Smoc2
|
UTSW |
17 |
14,589,295 (GRCm39) |
missense |
probably benign |
0.12 |
R5153:Smoc2
|
UTSW |
17 |
14,556,841 (GRCm39) |
missense |
probably damaging |
1.00 |
R5175:Smoc2
|
UTSW |
17 |
14,595,719 (GRCm39) |
missense |
possibly damaging |
0.89 |
R5239:Smoc2
|
UTSW |
17 |
14,589,227 (GRCm39) |
missense |
probably benign |
0.19 |
R5292:Smoc2
|
UTSW |
17 |
14,556,835 (GRCm39) |
missense |
probably damaging |
0.98 |
R5794:Smoc2
|
UTSW |
17 |
14,589,310 (GRCm39) |
missense |
possibly damaging |
0.94 |
R7810:Smoc2
|
UTSW |
17 |
14,545,884 (GRCm39) |
missense |
probably damaging |
1.00 |
R7996:Smoc2
|
UTSW |
17 |
14,595,730 (GRCm39) |
nonsense |
probably null |
|
R8811:Smoc2
|
UTSW |
17 |
14,545,896 (GRCm39) |
missense |
probably damaging |
1.00 |
R9214:Smoc2
|
UTSW |
17 |
14,556,839 (GRCm39) |
missense |
probably damaging |
1.00 |
R9287:Smoc2
|
UTSW |
17 |
14,619,686 (GRCm39) |
missense |
probably damaging |
1.00 |
X0026:Smoc2
|
UTSW |
17 |
14,556,895 (GRCm39) |
missense |
possibly damaging |
0.53 |
|
Predicted Primers |
PCR Primer
(F):5'- ATTGTCAGTGCCACTACTTTGG -3'
(R):5'- CAGGACTGGACCCATGATTCTG -3'
Sequencing Primer
(F):5'- CAGTGCCACTACTTTGGTTACGG -3'
(R):5'- GACCCATGATTCTGGAAGGTC -3'
|
Posted On |
2014-10-30 |